|11988 El Camino Real , San Diego, CA 92130|
|Fund Manager||Team Managed|
The Brandes Global Equity Fund (the Global Equity Fund or Fund ) seeks long term capital appreciation. The Global Equity Fund invests primarily in equity securities of U.S. and foreign companies. The Fund typically invests in companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion. A foreign company is determined to be foreign on the basis of its domicile, its principal place of business, its primary stock exchange listing, and/or the source of its revenues. Under normal market conditions, the Fund invests at least 80% of its net assets (plus any borrowings for investment purposes) measured at the time of purchase in equity securities. Equity securities include common and preferred stocks, warrants and rights. The Fund may invest up to 30% of its total assets, measured at the time of purchase, in securities of companies located in emerging market countries (including frontier market countries). The Fund may invest up to 5% of its total assets, measured at the time of purchase, in any one company. From time to time, the Fund may invest more than 25% of its assets in any market sector, such as the financial sector or healthcare sector. The Global Equity Fund may invest in companies located around the world. With respect to Fund investments in any particular country, the Fund may invest up to the greater of either (a) 20% of its total assets measured at the time of purchase, or (b) 150% of the weighting of such country as represented in the Morgan Stanley Capital International World ( MSCI World ) Index, measured at the time of purchase. As a result, the Fund may have significant exposure to any particular country. The Global Equity Fund will invest in at least three different countries, and invest at least 40% of its total assets (measured at the time of purchase) outside of the United States or, if conditions are not favorable, invest at least 30% of its total assets (measured at the time of purchase) outside of the United States. For example, if the Advisor determines that non-U.S. markets are generally overvalued compared to U.S. markets, the Fund may invest up to 70% of its total assets within the United States. The Global Equity Fund may invest from time to time in cash or short-term cash equivalent securities either as part of its overall investment strategy or for temporary defensive purposes in response to adverse market, economic, political or other conditions. The amount of such holdings will vary and will depend on the Advisor s assessment of the quantity and quality of investment opportunities that exist at any given time, and may at times be relatively high. Brandes Investment Partners, L.P., the Global Equity Fund s investment advisor (the Advisor ), uses the principles of value investing to analyze and select equity securities for the Fund s investment portfolio. When buying equity securities, the Advisor assesses the estimated intrinsic value of a company based on data such as a company s earnings, cash flow generation, and/or asset value of the underlying business. By choosing securities that are selling at a discount to the Advisor s estimates of the underlying company s intrinsic value, the Advisor seeks to establish an opportunity for long-term capital appreciation. The Advisor may sell a security when its price reaches the Advisor s estimate of the underlying company s intrinsic value, the Advisor believes that other investments are more attractive, or for other reasons.
|Asset Type||% Of Allocation|
|Total Net Assets||700.00 K|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$1000|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|BAC||BANK OF AMERICA CORPORATION||2.82%|
|UBS||UBS GROUP AG||2.63%|
|GSK||GLAXOSMITHKLINE PLC ADR||2.44%|
|MRK||MERCK & CO||2.40%|
|WFC||WELLS FARGO & CO||2.37%|
|EBS||ERSTE GROUP BANK AG||2.23%|
|BABA.N||ALIBABA GROUP HOLDING LTD||2.12%|
|PUBGY||PUBLICIS GROUPE SA||2.06%|
Join the Action Alerts PLUS Community today!
Bitcoin prices are getting smashed on Monday. So far support is holding, but is it dependable enough to buy? Let's look at the chart.
Li trims its forecast to 24,500 vehicle deliveries for the third quarter from 25,000 to 26,000.
Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.
Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.
Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.